Proteome and Egenix to Develop Semen-Screening Diagnostic for Prostate Cancer

Mar 07, 2006

NEW YORK, March 7 (GenomeWeb News) - Proteome and Egenix will co-develop a semen-based diagnostic kit for prostate cancer, Proteome said today.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.